Hepatitis C drug Harvoni drives earnings surge at Gilead
$1,000 a pill therapy makes sales of $3.58bn in first full quarter on market, focusing attention on healthcare costs
$1,000 a pill therapy makes sales of $3.58bn in first full quarter on market, focusing attention on healthcare costs
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Read the digital edition of The Gloss magazine now
Weddings, Births, Deaths and other family notices